دورية أكاديمية
Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain.
| العنوان: | Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain. |
|---|---|
| المؤلفون: | Kammerlander AA; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA akammerlander@mgh.harvard.edu.; Division of Cardiology, Medical University of Vienna, Vienna, Austria., Mayrhofer T; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany., Ferencik M; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR., Pagidipati NJ; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., Karady J; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Ginsburg GS; Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, Durham, NC., Lu MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Bittner DO; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Department of Cardiology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Puchner SB; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Bihlmeyer NA; Duke Molecular Physiology Institute, Durham, NC., Meyersohn NM; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Emami H; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Shah SH; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.; Duke Molecular Physiology Institute, Durham, NC., Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., Hoffmann U |
| مؤلفون مشاركون: | PROMISE Investigators |
| المصدر: | Diabetes care [Diabetes Care] 2021 Apr; Vol. 44 (4), pp. 1038-1045. Date of Electronic Publication: 2021 Feb 08. |
| نوع المنشور: | Journal Article; Multicenter Study; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Alexandria Va : American Diabetes Association Original Publication: New York, American Diabetes Assn. |
| مواضيع طبية MeSH: | Coronary Artery Disease*/diagnostic imaging , Metabolic Syndrome*/complications , Metabolic Syndrome*/epidemiology, Chest Pain/epidemiology ; Chest Pain/etiology ; Female ; Humans ; Male ; Middle Aged ; Phenotype ; Prospective Studies ; Risk Factors |
| مستخلص: | Objective: Obesity and metabolic syndrome are associated with major adverse cardiovascular events (MACE). However, whether distinct metabolic phenotypes differ in risk for coronary artery disease (CAD) and MACE is unknown. We sought to determine the association of distinct metabolic phenotypes with CAD and MACE. Research Design and Methods: We included patients from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) who underwent coronary computed tomography (CT) angiography. Obesity was defined as a BMI ≥30 kg/m 2 and metabolically healthy as less than or equal to one metabolic syndrome component except diabetes, distinguishing four metabolic phenotypes: metabolically healthy/unhealthy and nonobese/obese (MHN, MHO, MUN, and MUO). Differences in severe calcification (coronary artery calcification [CAC] ≥400), severe CAD (≥70% stenosis), high-risk plaque (HRP), and MACE were assessed using adjusted logistic and Cox regression models. Results: Of 4,381 patients (48.4% male, 60.5 ± 8.1 years of age), 49.4% were metabolically healthy (30.7% MHN and 18.7% MHO) and 50.6% unhealthy (22.3% MUN and 28.4% MUO). MHO had similar coronary CT findings as compared with MHN (severe CAC/CAD and HRP; P > 0.36 for all). Among metabolically unhealthy patients, those with obesity had similar CT findings as compared with nonobese ( P > 0.10 for all). However, both MUN and MUO had unfavorable CAD characteristics as compared with MHN ( P ≤ 0.017 for all). A total of 130 events occurred during follow-up (median 26 months). Compared with MHN, MUN (hazard ratio [HR] 1.61 [95% CI 1.02-2.53]) but not MHO (HR 1.06 [0.62-1.82]) or MUO (HR 1.06 [0.66-1.72]) had higher risk for MACE. Conclusions: In patients with stable chest pain, four metabolic phenotypes exhibit distinctly different CAD characteristics and risk for MACE. Individuals who are metabolically unhealthy despite not being obese were at highest risk in our cohort. (© 2021 by the American Diabetes Association.) |
| References: | Heart. 2020 Feb;106(4):273-279. (PMID: 31601728) N Engl J Med. 2019 Dec 19;381(25):2440-2450. (PMID: 31851800) Am Heart J. 2005 Oct;150(4):821-6. (PMID: 16209988) J Am Coll Cardiol. 2014 Jun 24;63(24):2679-86. (PMID: 24794119) JAMA. 1979 May 11;241(19):2035-8. (PMID: 430798) Eur Heart J. 2013 Feb;34(5):389-97. (PMID: 22947612) J Cardiovasc Comput Tomogr. 2019 Jul - Aug;13(4):211-218. (PMID: 30954400) Eur Heart J. 2020 Oct 1;41(37):3495-3497. (PMID: 33085966) Lancet Public Health. 2017 May 19;2(6):e277-e285. (PMID: 28626830) NCHS Data Brief. 2017 Oct;(288):1-8. (PMID: 29155689) Obesity (Silver Spring). 2014 Dec;22(12):2613-20. (PMID: 25155902) Lancet. 2004 Jan 10;363(9403):157-63. (PMID: 14726171) Circulation. 1998 May 12;97(18):1837-47. (PMID: 9603539) Curr Oncol Rep. 2016 Sep;18(9):56. (PMID: 27475805) Eur Heart J. 2018 May 1;39(17):1514-1520. (PMID: 29718151) JAMA Cardiol. 2018 Feb 1;3(2):144-152. (PMID: 29322167) Circulation. 1981 Feb;63(2):285-99. (PMID: 7449052) J Am Coll Cardiol. 2014 Aug 19;64(7):684-92. (PMID: 25125300) J Am Coll Cardiol. 2018 Sep 25;72(13):1506-1531. (PMID: 30236314) J Am Heart Assoc. 2019 Nov 5;8(21):e012860. (PMID: 31648578) Diabetes Care. 2012 Aug;35(8):1787-94. (PMID: 22699296) Am J Cardiol. 2008 Apr 15;101(8):1127-30. (PMID: 18394445) Ann Intern Med. 2015 May 5;162(9):610-8. (PMID: 25938991) Ann Intern Med. 2013 Dec 3;159(11):758-69. (PMID: 24297192) PLoS One. 2017 Jun 2;12(6):e0178741. (PMID: 28575097) Heart. 2007 Nov;93(11):1406-11. (PMID: 17540689) Eur Heart J. 2015 Mar 1;36(9):551-9. (PMID: 24670711) Eur Heart J. 2020 Jan 14;41(3):407-477. (PMID: 31504439) J Clin Endocrinol Metab. 2012 Jul;97(7):2482-8. (PMID: 22508708) J Clin Endocrinol Metab. 2019 Mar 1;104(3):738-752. (PMID: 30339231) J Am Coll Cardiol. 2007 Sep 18;50(12):1161-70. (PMID: 17868808) N Engl J Med. 2015 Apr 2;372(14):1291-300. (PMID: 25773919) JACC Heart Fail. 2017 Jan;5(1):56-63. (PMID: 28017350) J Am Coll Cardiol. 2019 Mar 5;73(8):893-902. (PMID: 30819356) J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. (PMID: 30894318) Cardiovasc Diabetol. 2017 Jan 25;16(1):14. (PMID: 28122619) JACC Cardiovasc Imaging. 2017 Sep;10(9):1031-1038. (PMID: 28330658) J Am Coll Cardiol. 2019 Sep 10;74(10):1376-1414. (PMID: 30894319) JAMA Cardiol. 2018 Apr 1;3(4):280-287. (PMID: 29490333) J Am Coll Cardiol. 2018 May 1;71(17):1857-1865. (PMID: 29699611) |
| معلومات مُعتمدة: | T32 HL076136 United States HL NHLBI NIH HHS; U01 HL123339 United States HL NHLBI NIH HHS; K24 HL113128 United States HL NHLBI NIH HHS; R01 HL098305 United States HL NHLBI NIH HHS; R01 HL098237 United States HL NHLBI NIH HHS; R01 HL098235 United States HL NHLBI NIH HHS; R01 HL098236 United States HL NHLBI NIH HHS; R01 HL109711 United States HL NHLBI NIH HHS |
| سلسلة جزيئية: | ClinicalTrials.gov NCT01174550 figshare 10.2337/figshare.13574531 |
| تواريخ الأحداث: | Date Created: 20210209 Date Completed: 20210916 Latest Revision: 20240817 |
| رمز التحديث: | 20240817 |
| مُعرف محوري في PubMed: | PMC7985425 |
| DOI: | 10.2337/dc20-1760 |
| PMID: | 33558267 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1935-5548 |
|---|---|
| DOI: | 10.2337/dc20-1760 |